CGEM Earnings

Quarterly EPS
$-0.51
Q4 2024
$-0.74
Q1 2025
$-1.19
Q2 2025
$-0.77
Q3 2025
$-0.49
Q4 2025
$-0.75
Q1 2026
$-0.87
Q2 2026
$-0.74
Q3 2026
Latest RevenueN/A
Latest Net Income-49388000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.740-49388000—+3.9%
Q2 2026-$0.870-53704000—+26.9%
Q1 2026-$0.750-49661000—-1.4%
Q4 2025-$0.490-50713000—+3.9%
Q3 2025-$0.770-50610000—-11.6%
Q2 2025-$1.190-70055000—-58.7%
Q1 2025-$0.740-48501000—+1.3%
Q4 2024-$0.510-47647000—-410.0%
Q3 2024-$0.690-40560000——
Q2 2024-$0.750-42028000——
Q1 2024-$0.750-37340000——
Q4 2023-$0.100-25563000——
Cullinan Therapeutics (CGEM) — Earnings